Improving health outcomes for Black preterm infants by addressing social factors
Identifying and addressing family-prioritized social drivers of health to improve the long-term health of Black preterm infants
This study is looking at how social issues, especially those related to racism, impact the health of Black babies born too early, and it aims to work with families to find out what support they need to help improve their babies' health in the long run.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11181496 on NIH RePORTER |
What this research studies
This research focuses on understanding how social factors, particularly those influenced by structural racism, affect the health of Black preterm infants. It aims to identify the specific social drivers of health that families prioritize and to develop interventions that can effectively address these factors. By evaluating the feasibility and acceptability of these interventions, the research seeks to improve long-term health outcomes for this vulnerable population. The study will involve collaboration with families to ensure that their needs and perspectives are central to the intervention design.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black families with preterm infants who are at risk for adverse health outcomes.
Not a fit: Patients who do not have preterm infants or are not part of the Black community may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health and neurodevelopmental outcomes for Black preterm infants.
How similar studies have performed: Previous research has shown that addressing social determinants of health can lead to improved health outcomes, indicating potential success for this approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Karvonen, Kayla — University of California, San Francisco
- Study coordinator: Karvonen, Kayla
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.